We first hypothesized that p300 was the central factor leading to the reduction of α-MHC K1897 lactylation during heart failure, and p300 activator may restore the decreased α-MHC K1897 lactylation and α-MHC–Titin interaction during heart failure. Here, TTN is linked to heart failure.